GALMED PHARMACEUTICALS LTD
SHS · CUSIP M47238106
0
institutional holders
-22 vs Q1 2023
—reported value*
0 new
0 added
0 reduced
22 sold out
net sold ≈ $878.3k (-2.1m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 26 |
| Q4 2022 | 23 |
| Q1 2023 | 22 |
| Q2 2023 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 6 | 18 |
| Q1 2023 | 6 | 10 |
| Q2 2023 | 0 | 22 |
Biggest buyers
| None |
Biggest sellers
| BVF INC/IL | Sold out | -1.3m |
| MORGAN STANLEY | Sold out | -204.2k |
| RAYMOND JAMES & ASSOCIATES | Sold out | -138.0k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -131.6k |
| CITADEL ADVISORS LLC | Sold out | -40.8k |
| Virtu Financial LLC | Sold out | -31.6k |
| Western Wealth Management, LLC | Sold out | -29.5k |
| Cambridge Investment Research Advisors, Inc. | Sold out | -28.5k |
| Raymond James Financial Services Advisors, Inc. | Sold out | -27.9k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -27.2k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|